Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant for Cannabis Dependence
NCT01611948Phase 2Completed
- Sponsor
- Scripps Research
- Start
- May 2011
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aprepitant in cannabis use disorder (CUD), sponsored by Scripps Research. Started May 2011; status: completed.
02
Drugs
aprepitant
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT01611948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01611948.